Torsdag 26 December | 17:45:01 Europe / Stockholm

Bifogade filer

Kalender

Tid*
2025-11-06 13:30 Kvartalsrapport 2025-Q3
2025-08-21 13:30 Kvartalsrapport 2025-Q2
2025-05-08 13:30 Kvartalsrapport 2025-Q1
2025-02-27 08:00 Bokslutskommuniké 2024
2024-12-18 - Extra Bolagsstämma 2024
2024-11-07 - Kvartalsrapport 2024-Q3
2024-08-21 - Kvartalsrapport 2024-Q2
2024-05-16 - X-dag ordinarie utdelning STENO 0.00 DKK
2024-05-15 - Årsstämma
2024-05-02 - Kvartalsrapport 2024-Q1
2024-02-22 - Bokslutskommuniké 2023
2023-11-09 - Kvartalsrapport 2023-Q3
2023-08-17 - Kvartalsrapport 2023-Q2
2023-06-20 - Kvartalsrapport 2023-Q1
2023-06-13 - Extra Bolagsstämma 2023
2023-05-22 - X-dag ordinarie utdelning STENO 0.00 DKK
2023-02-23 - Bokslutskommuniké 2022
2022-11-18 - Extra Bolagsstämma 2022
2022-11-09 - Kvartalsrapport 2022-Q3
2022-08-18 - Kvartalsrapport 2022-Q2
2022-05-20 - X-dag ordinarie utdelning STENO 0.00 DKK
2022-05-19 - Årsstämma
2022-05-05 - Kvartalsrapport 2022-Q1
2022-02-24 - Bokslutskommuniké 2021
2021-11-04 - Kvartalsrapport 2021-Q3
2021-08-19 - Kvartalsrapport 2021-Q2
2021-05-21 - X-dag ordinarie utdelning STENO 0.00 DKK
2021-05-20 - Årsstämma
2021-05-06 - Kvartalsrapport 2021-Q1
2021-02-25 - Bokslutskommuniké 2020
2020-11-05 - Kvartalsrapport 2020-Q3
2020-08-20 - Kvartalsrapport 2020-Q2
2020-05-15 - X-dag ordinarie utdelning STENO 0.00 DKK
2020-05-14 - Årsstämma
2020-05-07 - Kvartalsrapport 2020-Q1
2020-02-26 - Bokslutskommuniké 2019
2019-11-06 - Kvartalsrapport 2019-Q3
2019-08-20 - Kvartalsrapport 2019-Q2
2019-05-07 - Kvartalsrapport 2019-Q1
2019-02-21 - Bokslutskommuniké 2018

Beskrivning

LandDanmark
ListaFirst North Denmark
SektorHälsovård
IndustriLäkemedel & Handel
Stenocare är verksamt inom hälsovårdsindustrin. Bolaget är specialiserat inom utveckling av medicinsk cannabis. Stenocare är en av de första aktören att ha påbörjat försäljning av medicinska cannabisoljor i Danmark. Bolaget kommer framöver även vända sig till övriga europeiska marknader med sitt produktutbud. Stenocares huvudkontor ligger i Randers.
2023-06-05 08:00:00

STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER:  STENO

STENOCARE A/S ("Stenocare") is currently offering its shareholders and new investors to join its public issue with a formal last day on Thursday, June 8, 2023. investors should be aware that Nordnet has defined Tuesday June 6 as the deadline to subscribe in their system.

Note: Monday, June 5, 2023 is a bank holiday in Denmark (Grundlovsdag), and Tuesday June 6 is a bank holiday in Sweden (Nationaldag). Nordnet is open for online subscription both days.

Clarification and recommendation to act now: Stenocare provides this clarification in response to several questions received about the last day of subscription. The last day at which the issuing bank (Danske Bank) must receive any subscriptions - with or without rights - is Thursday, June 8, 2023, but certain banks - such as Nordnet - have decided to reserve some time for their expedition of customer orders to Danske Bank. Customers of Danske Bank can submit their subscriptions from clients all the way to June 8, 2023, but all interested subscribers must subscribe asap and follow the instructions and deadlines of their own banks.

Last day of trading in rights: In any case, the formal deadline for purchase of unit rights - which is the instrument that can be purchased by anyone that does not have (enough) rights from an existing holding of shares - is June 6, 2023. Also, subscription can be made without the backing of rights. This is done digitally through Nordnet/Avanza or by filling in and sending the special form for subscription without rights to the bank: https://stenocare.com/wp-content/uploads/2023/05/SUBSCRIPTION-FORM-without-use-of-Unit-Rights-ENG-.pdf

About the issue: The ongoing public share issue is for Units, at a price per unit of DKK 9.16, including 2 shares (at DKK 4.58 each) and 2 free warrants. The unit rights issue amounts to up to 10,7mDKK and is backed by pre-subscription from management, board and others, as well as guarantors, amounting to a total of 86% of the issue and lenders that have committed to convert into Units. In total, this corresponds to more than 100% of the issue, but in order to make room for public subscription if needed, the conversion of debt will take place in a separate directed issue, in addition to the public issue. Links:

https://www.nordnet.dk/dk/kampagner/emission/stenocare

https://stenocare.com/share-issue-2023/

Minimum requirement: Please notice that according to Nasdaq policy there is a minimum subscription of Euro 500 for investors without Unit Rights - which is approx. equal to 407 Units. However, investors that like to subscribe for less than 407 Units can purchase Unit Rights for the desired number of Units (for each Unit the investor need to purchase 10 Unit Rights). The price of a Unit Right (ticker: "STENO UR") is available from the bank or from Nasdaq STENO UR, Stenocare A/S UR, (DK0062493458) - Nasdaq (nasdaqomxnordic.com) (https://www.nasdaqomxnordic.com/aktier/microsite?Instrument=CSE293091&name=Stenocare%20A%2FS%20UR)